PuSH - Publikationsserver des Helmholtz Zentrums München

Fino, R. ; Byrne, R.* ; Softley, C. ; Sattler, M. ; Schneider, G.* ; Popowicz, G.M.

Introducing the CSP analyzer: A novel machine learning-based application for automated analysis of two-dimensional NMR spectra in NMR fragment-based screening.

Comp. Struc. Biotech. J. 18, 603-611 (2020)
Verlagsversion DOI
Open Access Gold
Creative Commons Lizenzvertrag
NMR-based screening, especially fragment-based drug discovery is a valuable approach in early-stage drug discovery. Monitoring fragment-binding in protein-detected 2D NMR experiments requires analysis of hundreds of spectra to detect chemical shift perturbations (CSPs) in the presence of ligands screened. Computational tools are available that simplify the tracking of CSPs in 2D NMR spectra. However, to the best of our knowledge, an efficient automated tool for the assessment and binning of multiple spectra for ligand binding has not yet been described. We present a novel and fast approach for analysis of multiple 2D HSQC spectra based on machine-learning-driven statistical discrimination. The CSP Analyzer features a C# frontend interfaced to a Python ML classifier. The software allows rapid evaluation of 2D screening data from large number of spectra, reducing user-introduced bias in the evaluation. The CSP Analyzer software package is available on GitHub https://github.com/rubbs14/CSP-Analyzer/releases/tag/v1.0 under the GPL license 3.0 and is free to use for academic and commercial uses.
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter 2-d Nmr ; Automatic Csp Analysis ; C# Gui ; Fragment Screening ; Fragment-based Drug Discovery ; Machine-learning; Difference Std Nmr; Drug-binding; Spectroscopy; Software; Relaxation; Proteins; Ligands
ISSN (print) / ISBN 2001-0370
e-ISSN 2001-0370
Quellenangaben Band: 18, Heft: , Seiten: 603-611 Artikelnummer: , Supplement: ,
Verlag Research Network of Computational and Structural Biotechnology (RNCSB)
Verlagsort Radarweg 29, 1043 Nx Amsterdam, Netherlands
Begutachtungsstatus Peer reviewed
Förderungen Helmholtz Association Initiative and Networking Funds
Accelerated Early staGe drug dIScovery (AEGIS)
European Union